Autolus Therapeutics plc Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Autolus Therapeutics plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2018 to Q3 2024.
  • Autolus Therapeutics plc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $4.02M, a 40.4% increase year-over-year.
  • Autolus Therapeutics plc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $12.5M.
  • Autolus Therapeutics plc annual Share-based Payment Arrangement, Expense for 2023 was $11.3M, a 6.36% decline from 2022.
  • Autolus Therapeutics plc annual Share-based Payment Arrangement, Expense for 2022 was $12M, a 20.9% increase from 2021.
  • Autolus Therapeutics plc annual Share-based Payment Arrangement, Expense for 2021 was $9.94M, a 50.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $12.5M $4.02M +$1.16M +40.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $11.4M $2.94M +$267K +10% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $11.1M $2.28M -$132K -5.46% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-17
Q4 2023 $11.3M $3.3M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $2.86M -$473K -14.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $2.67M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $2.42M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q3 2022 $3.34M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q1 2021 $13.1M -$670K -$6.91M -111% Jan 1, 2021 Mar 31, 2021 6-K 2021-05-06
Q4 2020 $20M $4.24M -$2.21M -34.3% Oct 1, 2020 Dec 31, 2020 20-F 2023-03-07
Q3 2020 $22.2M $4.25M -$3.46M -44.9% Jul 1, 2020 Sep 30, 2020 6-K 2020-11-05
Q2 2020 $25.7M $5.31M -$3.56M -40.2% Apr 1, 2020 Jun 30, 2020 6-K 2020-08-06
Q1 2020 $29.3M $6.24M -$1.13M -15.3% Jan 1, 2020 Mar 31, 2020 6-K 2021-05-06
Q4 2019 $30.4M $6.45M +$3.05M +90% Oct 1, 2019 Dec 31, 2019 20-F 2022-03-10
Q3 2019 $27.3M $7.71M Jul 1, 2019 Sep 30, 2019 6-K 2020-11-05
Q2 2019 $8.87M +$6.49M +273% Apr 1, 2019 Jun 30, 2019 6-K 2020-08-06
Q1 2019 $7.37M Jan 1, 2019 Mar 31, 2019 6-K 2020-05-07
Q4 2018 $3.39M Oct 1, 2018 Dec 31, 2018 20-F 2021-03-04
Q2 2018 $2.38M Apr 1, 2018 Jun 30, 2018 6-K 2019-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.